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Abstract
Background: Due to their intrinsic properties, stem cells are promising tools for new developments in tissue
engineering and particularly for cartilage tissue regeneration. Although mesenchymal stromal/stem cells from bone
marrow (BM-MSC) have long been the most used stem cell source in cartilage tissue engineering, they have certain
limits. Thanks to their properties such as low immunogenicity and particularly chondrogenic differentiation
potential, mesenchymal stromal/stem cells from Wharton’s jelly (WJ-MSC) promise to be an interesting source of
MSC for cartilage tissue engineering.
Methods: In this study, we propose to evaluate chondrogenic potential of WJ-MSC embedded in alginate/
hyaluronic acid hydrogel over 28 days. Hydrogels were constructed by the original spraying method. Our main
objective was to evaluate chondrogenic differentiation of WJ-MSC on three-dimensional scaffolds, without adding
growth factors, at transcript and protein levels. We compared the results to those obtained from standard BM-MSC.
Results: After 3 days of culture, WJ-MSC seemed to be adapted to their new three-dimensional environment
without any detectable damage. From day 14 and up to 28 days, the proportion of WJ-MSC CD73+, CD90+, CD105+
and CD166+ decreased significantly compared to monolayer marker expression. Moreover, WJ-MSC and BM-MSC
showed different phenotype profiles. After 28 days of scaffold culture, our results showed strong upregulation of
cartilage-specific transcript expression. WJ-MSC exhibited greater type II collagen synthesis than BM-MSC at both
transcript and protein levels. Furthermore, our work highlighted a relevant result showing that WJ-MSC expressed
Runx2 and type X collagen at lower levels than BM-MSC.
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Conclusions: Once seeded in the hydrogel scaffold, WJ-MSC and BM-MSC have different profiles of chondrogenic
differentiation at both the phenotypic level and matrix synthesis. After 4 weeks, WJ-MSC, embedded in a three-
dimensional environment, were able to adapt to their environment and express specific cartilage-related genes
and matrix proteins. Today, WJ-MSC represent a real alternative source of stem cells for cartilage tissue
engineering.
Keywords: Alginate/hyaluronic acid hydrogel, Chondrogenic differentiation, Cartilage tissue engineering,
Mesenchymal stromal/stem cells, Wharton’s jelly
Background
Once damaged, cartilage tissue has limited self-repair cap-
acity. Today, traumatic and degenerative articular cartilage
damage can only be treated symptomatically (analgesics
and anti-inflammatory drugs) or by surgery (mosaico-
plasty, microfracture, autologous chondrocyte implant-
ation) in order to delay joint replacement. However, these
methods fail to restore native tissue integrity and lead to
the formation of fibrocartilage [1] which is functionally in-
ferior to hyaline cartilage. For these reasons, scientists and
clinicians consider cartilage tissue engineering to be a po-
tential alternative treatment for cartilage repair. Tissue en-
gineering uses three basic elements: a suitable cell source,
a biocompatible scaffold and environmental factors [2] to
produce in vitro or in situ neotissue. These three elements
can be combined or used separately to repair cartilage de-
fect. Several investigators preferred transplantation of cells
only combined with scaffold to create functional tissue
replacement in situ [3]. Three-dimensional (3D) scaf-
folds must be able to mimic the physiological environment
and ensure attachment, proliferation and differentiation of
cells. Due to their intrinsic properties, stem cells are prom-
ising tools for new tissue engineering developments and
particularly for cartilage tissue regeneration. Owing to eth-
ical considerations and the random efficiency of chondro-
genic differentiation [4], the use of embryonic stem cells is
not the most appropriate. Thus, mesenchymal stromal/
stem cells (MSC) are an attractive source of cells for cartil-
age tissue engineering.
MSC from bone marrow (BM-MSC) remain the most
studied stem cell source used in cartilage tissue engineer-
ing [5, 6]. However, bone marrow collection is a painful
and invasive procedure with the possibility of donor site
damage. In addition, it has been demonstrated that the
number of available BM-MSC is quite low in this com-
partment [7], and their differentiation potential and prolif-
eration capacity decrease with age [8, 9]. Consequently,
the use of autologous BM-MSC for tissue repair, which in
some indications concerns elderly patients, has certain
limits. Thus, identifying alternative sources of MSC would
be very helpful.
Due to their properties such as low immunogenicity [10]
and, particularly, chondrogenic differentiation potential
[11], MSC from the connective tissue of umbilical cord
named Wharton’s jelly (WJ-MSC) promise to be an in-
teresting source of MSC for cartilage tissue engineering
[12]. Several studies have already demonstrated the
potential of WJ-MSC for chondrogenic differentiation
in 3D cultures. WJ-MSC were embedded in natural
scaffolds such as type I collagen hydrogel [13] or in
synthetic polymer scaffolds such as polyglycolic acid
meshes [14], and polyvinyl alcohol-polycaprolactone
[15]. Cells were cultivated for 3 to 4 weeks in chondro-
genic medium supplemented with growth factors (such
as transforming growth factor (TGF)-β1 and TGF-β3
and bone morphogenic protein (BMP)2) used alone or
in combination [15]. These works showed the success-
ful chondrogenic induction of WJ-MSC in 3D scaffolds
with expression of specific cartilage-related genes and
matrix proteins (Sox9, aggrecan, type II collagen, and
cartilage oligomeric matrix protein (COMP)).
Alginate hydrogel is an in vitro and in vivo biocompat-
ible scaffold [16], and a hydrophilic polymer network
which creates a porous microstructure ensuring nutrient
diffusion, cell to cell contact, cell proliferation and differ-
entiation [17]. Various studies have already shown that
MSC embedded in alginate hydrogel represent a relevant
model for chondrogenesis of human MSC and study of
the molecular mechanisms involved in chondrogenic
differentiation [6, 17]. Hyluronic acid (HA) is a natural
component of native cartilage and HA hydrogel can
support and promote the chondrogenic differentiation of
MSC [18]. According to a recent in vivo study, HA is an
attractive hydrogel candidate for cartilage tissue engin-
eering [19].
In this study, we propose to evaluate chondrogenic po-
tential of WJ-MSC embedded in alginate/hyaluronic acid
(Alg/HA) hydrogel. Hydrogels were constructed by an
original spraying method which has been previously
described [6, 20]. Our main objective is to evaluate
chondrogenic differentiation of WJ-MSC in a 3D scaf-
fold, without adding growth factors, at transcript and
protein levels. To conclude whether WJ-MSC represent
a real alternative source of stem cells for cartilage tissue
engineering, we compared the results to those obtained
from standard BM-MSC.
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Methods
Isolation and culture of MSC
WJ-MSC and BM-MSC were isolated and cultivated as
previously described [12]. Human umbilical cords and
bone marrow were collected after patients’ informed
consent; this complied with national legislation regard-
ing human sample collection, manipulation and personal
data protection. These biological samples were regarded
as surgical waste and therefore, following the opinion of
an ethics committee of Nancy Hospital, no authorization
of this committee was necessary for their collection.
BM-MSC were only used as a standard control.
Umbilical cord samples, from three donors, were rinsed
with 70 % ethanol and Hanks’ balanced salt solution
(HBSS). To perform MSC isolation, the umbilical cord
vessels were removed and Wharton’s jelly aseptically cut
into small pieces (2 to 3 mm3) which were plated in a six-
well plate with complete medium (minimal Eagle medium
(α-MEM; Lonza, Walkersville, MD, USA) with 10 % fetal
bovine serum, glutamine 2 mM, penicillin 100 IU/mL,
streptomycin 100 μg/mL and amphotericin B 2.5 μg/mL).
They were incubated at 37 °C under a humidified atmos-
phere with 5 % CO2 in normoxia. After 7 days of contact
with the plastic surface the cells migrated and, as enough
adherent cells were obtained, the pieces were removed,
the medium replaced and cultures continued until cell
subconfluence (80–90 %). After 2 weeks, WJ-MSC were
harvested with 0.25 % Trypsin-EDTA (Sigma-Aldrich, St.
Louis, MO, USA) and grown up to passage (P)3.
Bone marrow samples from five donors aged from 25
to 60 years were aspirated and diluted in HBSS. Nuclear
cells were counted and the cell suspension was seeded at
50,000 nuclear cells/cm2 with complete medium. They
were incubated at 37 °C under a humidified atmosphere
with 5 % CO2 in normoxia. BM-MSC migrated, adhered
to the plastic surface and were cultivated up to subcon-
fluence (P0). After 2 to 3 weeks, cells were harvested
with Trypsin-EDTA, seeded with complete medium at
1000 cells/cm2 and grown up to P3.
Scaffold construct and chondrogenic differentiation
After expansion, at the end of the third passage, WJ-MSC
and BM-MSC were harvested with Trypsin-EDTA and
seeded at 3 × 106 cells/mL of Alg/HA hydrogel (Fig. 1).
Scaffolds were built up with one hydrogel layer seeded
with MSC. Hydrogel was composed of 1.5 % (m/v) Alg
Fig. 1 Illustration of protocol steps used to perform scaffold construct and chondrogenic differentiation. After monolayer expansion, MSC were
seeded at 3× 106 cells/mL of Alg/HA hydrogel. Hydrogel was sprayed, gelated, and cut into 5 mm diameter cylinders; scale bar = 5 mm. Scaffolds
were cultivated in a 48-well plate in differentiation medium for 28 days. Alg/HA alginate/hyaluronic acid, MSC mesenchymal stromal/stem cells, P3
passage 3
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(medium viscosity, Sigma, France) and HA (Accros,
France) (ratio 4:1) dissolved in 0.9 % NaCl. The spray-
ing method used was previously described with rat
chondrocytes [20] and human MSC [6]. The spraying
system consisted of an airbrush working with a com-
pressor to induce spraying, with pressure being equal
to 0.9 bar. The spraying bottle containing the homoge-
nized cellular suspension in Alg/HA hydrogel was con-
nected to the airbrush, and then solution was sprayed
on a sterile glass plate. After hydrogel gelation in a CaCl2
bath at 102 mM for 10 minutes, cylinders were cut at
5 mm diameter and 2 mm thickness with a biopsy punch
(Fig. 1).
For viability analysis, WJ-MSC were also seeded in Alg/
HA hydrogel beads, manufactured as previously described
[21], by simple encapsulation without spraying and used
as a control.
Scaffolds were cultivated in a 48-well plate in differenti-
ation medium containing DMEM-high glucose (Gibco,
Grand Island, NY) supplemented with 10 % fetal bovine
serum (Gibco), glutamine 2 mM (Sigma), penicillin 100
U/mL (Sigma), streptomycin 100 μg/mL (Sigma), ampho-
tericin B 2.5 μg/mL (Sigma), 100 μg/mL sodium pyruvate
(Sigma), 40 μg/mL L-Proline (Sigma), 50 μg/mL L-acid
ascorbic (Sigma), 100 nM dexamethasone (Sigma) and
1 mM CaCl2 (Sigma). Scaffolds were incubated at 37 °C
under a humidified atmosphere with 5 % CO2 in nor-
moxia for 28 days and differentiation medium was chan-
ged twice a week (Fig. 1).
During chondrogenic differentiation, after 3, 14 and
28 days of culture, cells were extracted from Alg/HA
hydrogel by dissolution in 55 mM sodium citrate (Sigma)
and 50 mM EDTA solution (Merck, Darmstadt, Germany)
for 5 minutes. After centrifugation (320 g, 5 minutes), via-
bility, phenotype and mRNA expression were analyzed.
Only at 28 days of culture were other scaffolds used for
histological processing. WJ-MSC viability was also evalu-
ated for two methods of scaffold construct: alginate beads
and alginate cylinders (obtained by spraying method) at 3,
7 and 10 days of culture.
Viability, apoptosis and necrosis analysis
Apoptosis and necrosis of cells were analyzed by flow cy-
tometry using the Vybrant/ApoptosisTM kit based on the
AnnexinV/propidium iodide (PI) staining procedure (Invi-
trogen, Carlsbad, CA). Cells were suspended in 100 μL 1×
Annexin-liant buffer with 2.5 μL Annexin V-Alexa 488
and 1 μL PI (100 μg/mL), for 15 minutes at room
temperature. After incubation, 200 μL 1× Annexin V buf-
fer were added to each sample. Then, cells were analyzed
by measuring fluorescence emission at 530 nm and
575 nm, respectively, for Alexa 488 (apoptotic cells) and
PI (necrotic cells) with a Gallios flow cytometer (Beckman
Coulter, Brea, CA, USA). Negative (unlabeled cells) and
positive controls (apoptosis and necrosis) were performed
(Fig. 2a). Apoptosis was induced by incubating anti-Fas
mouse antibody (Enzo Life Sciences, Farmingdale, NY,
USA) with the cells for 1 hour. After washing, a second
anti-mouse IgG3 antibody (BD, Franklin Lakes, NJ, USA)
was incubated for 1 hour with cells and, finally, cells were
labeled only with Annexin V-Alexa 488. Cell necrosis was
induced by adding Triton X-100 solution (Sigma) for 1 -
minute before centrifugation (300 g, 5 minutes) and PI
labeling. For all analyses, at least 5000 events were ana-
lyzed. Viable cells were Annexin V − and PI −.
Phenotypic analysis
Phenotypic analysis of MSC was performed during mono-
layer expansion (prior to encapsulation in the hydrogel)
and throughout scaffold culture. Briefly, to perform
phenotypic analysis MSC were incubated with fluorescein
isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated
mouse anti-human antibodies CD34-PE, CD45-FITC,
HLA-DR-FITC, CD44-FITC, CD73-PE, CD90-FITC,
CD105-PE and CD166-PE (Beckman Coulter, Brea, CA,
USA) for 30 minutes at room temperature. Negative and
isotype (FITC and PE) controls were performed. After
immunofluorescence staining, for each sample 10,000
events were counted by Gallios flow cytometer (Beckman
Coulter, Brea, CA, USA).
Transcript analysis
MSC were rinsed with phosphate-buffered saline three
times to remove residual alginate. Total RNA was
extracted by RNeasy Plus mini kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
RNA yield was evaluated by spectrophotometry and
RNA quality was analyzed by electrophoresis through a
1 % agarose gel. RNA was then reverse-transcripted to
cDNA using iScript™ cDNA Synthesis Kit (Bio-rad,
Hercules, CA, USA). Quantitative polymerase chain re-
action (PCR) was performed using iTaq™ Universal
SYBR® Green Supermix (Bio-rad) and a Light Cycler
system (Roche Diagnostics, Basel, Switzerland) during
45 cycles to quantitatively analyze gene expression.
Values were normalized to expression of RP29 mRNA.
Table 1 lists the specific primers used.
Matrix synthesis
Matrix synthesis was evaluated by histology, immuno-
fluorescence staining and immunohistochemistry. After
28 days of chondrogenic differentiation, Alg/HA scaffolds
were fixed in 4 % paraformaldehyde (Sigma), 100 mM so-
dium cacodylate (Sigma) and 10 mM CaCl2 (Sigma) solu-
tion (pH 7.4) for 4 hours and then washed overnight in
100 mM sodium cacodylate and 50 mM BaCl2 (Sigma)
buffer (pH 7.4). The scaffolds were dehydrated, embedded
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Table 1 List of polymerase chain reaction primers used for the present study
Name Forward primer (5′–3′) Reverse primer (5′–3′) TM (°)
RP29 AAGATGGGTCACCAGCAGCTCTACTG AGACGCGGCAAGAGCGAGAA 60
Sox9 GAGCAGACGCACATCTC CCTGGGATTGCCCCGA 55
Aggrecan TCGAGGACAGCGAGGCC TCGAGGGTGTAGCGTGTAGAGA 62
COMP ACAATGACGGAGTCCCTGAC TCTGCATCAAAGTCGTCCTG 60
Type IIa collagen GCAGGATGGGCAGAGGTAT ATCTCAGGGCTGAGGCAGT 60
Total II collagen ATGACAATCTGGCTCCCAAC GAACCTGCTATTGCCCTCTG 55
Type X collagen GCTAAGGGTGAAAGGGGTTC CTCCAGGATCACCTTTTGGA 60
Runx2 CCCGTGGCCTTCAAGGT CGTTACCCGCCATGACAGTA 56
PPAR γ TTCAGAAATGCCTTGCAGTG CCAACAGCTTCTCCTTCTCG 58
Fig. 2 Changes in MSC viability during scaffold culture. Cell viability was measured by flow cytometry at 3, 14 and 28 days of culture of MSC embedded in
Alg/HA hydrogel. Necrotic and apoptotic cells were labeled with propidium iodide and annexin V–Alexa 488, respectively. a Positive controls for apoptotic
and necrotic cells. b Cell viability was evaluated after spraying method of scaffold construct between BM-MSC and WJ-MSC. c WJ-MSC viability
was evaluated for two methods of scaffold construct: alginate beads and alginate cylinders (obtained by spraying method) at 3, 7 and 10 days
of culture. The results are expressed as mean ± standard error of the mean (n ≥ 3). *p < 0.05 and **p < 0.01, day x vs day 3 for the same cell
source (b) or method of scaffold construct (c). #p < 0.05, cylinders vs beads for the same culture time. BM-MSC bone marrow-derived mesenchymal
stromal/stem cells, WJ-MSC Wharton’s ielly-derived mesenchymal stromal/stem cells
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in paraffin blocks, cut into 5 μm thick sections and
mounted onto glass slides.
For histological analysis, total collagen and proteogly-
cans were stained by Sirius red and Alcian Blue, respect-
ively, and observed by light microscopy (DMD 108, Leica,
Wetzlar, Germany).
For immunofluorescence staining, hydrogel sections
were deparaffinized and permeabilized with 0.1 % Triton
X-100 (Sigma) for 20 minutes and then blocked with
0.5 % bovine serum albumin (Sigma) in DMEM without
phenol red (Gibco) for 15 minutes at room temperature.
Specimens were incubated for 45 minutes with rabbit
anti-human type I, II, or X collagen antibodies (1:50)
(Merck, Darmstadt, Germany). After a washing step,
samples were incubated for 45 minutes with secondary
antibody: a goat anti-rabbit IgG Alexa Fluor 488 (1:50)
(Invitrogen, Carlsbad, CA, USA). Negative and isotype
controls were also performed. Immunofluorescence label-
ing was detected using fluorescence microscopy (DMI
3000B, Leica, Wetzlar, Germany).
Immunohistochemistry with antibodies for collagen type
type I, II and X was performed according to LSAB® + kit
(HRP, Dako) based on avidin-biotin techniques. Primary
monoclonal antibodies collagen I (T59103R, Biodesign)
and collagen II (6B3, Labvision) were used at the dilution
of 1/100 and collagen X (Ab49945, Abcam) was used at
the dilution of 1/1000. Paraffin-embedded tissue sections
of 5 μm were deparaffinized through a series of alcohols
and treated with pepsin (0.4 % w/v in 0.01 M HCl, pH 2.0,
Sigma) for 30 minutes at room temperature. Slides were
then incubated with hydrogen peroxide block solution for
5 minutes to block endogenous peroxidase. After washing,
2 % bovine serum albumin solution was applied for 10 mi-
nutes at room temperature to block the unspecific epi-
tope. The primary antibody was added to each slide and
slides were incubated at room temperature in a humidified
chamber for 1 hour. Subsequently, the samples were incu-
bated with a biotinylated link secondary antibody for
45 minutes at room temperature. Peroxidase-labeled step-
tavidin was applied at room temperature for 30 minutes.
Substrate-chromogen solution was prepared with diami-
nobenzidine (DAB, LSAB® + kit, Dako) and incubated to
the specimen and monitored under a microscope for the
desired stain intensity. Control groups for immunohisto-
chemical analysis were performed under identical condi-
tions on human cartilage for positive control or without
primary antibodies for negative control. Finally the sec-
tions were counterstained with hematoxylin at 1/5 for
1 minute (RAL, France) and mounted with Eukit resin.
Statistical analysis
Statistical tests and graphic representations were per-
formed using graphPad Prism 5 software (GraphPad,
San Diego, CA, USA). All the data are presented as
mean ± standard error of the mean of independent ex-
periments with cells from different donors that were
pooled. Significant statistical differences were calculated
using one- or two-way analysis of variance. A p-value
less than 0.05 was considered significant for the analyses
of variance. If significance existed, a post-hoc analysis
was performed using the Bonferonni post-tests to evalu-
ate significance for all experiments.
Results
Viability, apoptosis and necrosis analysis
Cell viability, apoptosis and necrosis were analyzed 3,
14 and 28 days after spraying method of scaffold con-
struct and data were compared to BM-MSC (Fig. 2b).
After 3 days of culture, WJ-MSC viability was 58 ± 4 %.
From 14 days, viability significantly increased (p < 0.05)
and became greater than 80 % until 28 days. Mean-
while, apoptosis and necrosis decreased from 14 up to
28 days (data not shown). No significant difference was
observed between WJ-MSC and BM-MSC. To under-
stand WJ-MSC behavior in early culture, the same pa-
rameters were evaluated using two methods of scaffold
construct, alginate beads and alginate cylinders ob-
tained by spraying method, between 3 and 10 days after
build-up (Fig. 2c). The results indicated clearly that at
the third day of culture the viability of sprayed cells
was significantly lower than in cells embedded in algin-
ate beads (p < 0.05). At the same time, cell apoptosis
was significantly higher in cylinders compared to cells
seeded in beads (p < 0.05) (data not shown).
Phenotypic analysis
Flow cytometry showed that, regardless of the time of
culture or the cell source, MSC were negative for the
hematopoietic markers CD34, CD45 and HLA-DR
(Fig. 3a). Less than 5 % of cells expressed these surface
markers. WJ-MSC from the monolayer to the end of
3D culture variably expressed mesenchymal markers
such as CD44, CD73, CD90, CD105 and CD166
(Fig. 3b). During monolayer expansion, the proportion
of CD44+, CD73+ and CD105+ cells were significantly
higher (at least 20 %) in WJ-MSC compared to BM-
MSC (p < 0.001, p < 0.05 and p < 0.01, respectively). No
difference was reported for CD90 and CD166 expres-
sion. In the 3D environment and during chondrogenic
differentiation, the proportions of positive WJ-MSC for
mesenchymal markers (except CD44) decreased signifi-
cantly from 14 and up to 28 days, in comparison with
monolayer expansion. On the other hand, the propor-
tion of CD44+ cells remained relatively constant. From
14 days, positive expression for mesenchymal markers
seemed to be less for WJ-MSC than for BM-MSC, es-
pecially for CD90 and CD166 which were significantly
reduced (p < 0.05).
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Transcript analysis
Relative expression of specific cartilage-related genes was
evaluated by quantitative RT-PCR during chondrogenic
differentiation. Relative expression of other mesodermic
lineage markers such as Runx2 or PPARγ was also re-
ported (Fig. 4). While aggrecan and type IIa collagen ex-
pression seemed to increase during 3D culture of WJ-
MSC, Sox9, COMP and total type II collagen expres-
sion by WJ-MSC were significantly higher compared to
early stages of chondrogenesis (p < 0.01). After 28 days
of chondrogenic induction, type IIa and total type II
collagens were significantly more expressed by WJ-MSC
than by BM-MSC (p < 0.001). Conversely, COMP expres-
sion was lower in WJ-MSC compared to standard BM-
MSC (p < 0.001). Hypertrophic cartilage markers, Runx2
and type X collagen, were also analyzed during chondro-
genic differentiation. Our results showed that Runx2 and
type X collagen were very weakly expressed by WJ-MSC
throughout culture compared to BM-MSC (p < 0.001 after
28 days of chondrogenic induction). Regardless of MSC
source, no expression of adipogenic transcription factor
PPARγ was detected during differentiation.
Matrix synthesis
To study chondrogenic differentiation, matrix synthesis
was detected after 28 days of induction. Proteoglycans
and total collagen were stained by Alcian blue and Sirius
red (Fig. 5a), respectively. According to histological la-
beling, matrix synthesis remained pericellular and total
collagen synthesis seemed to be greater in WJ-MSC
Fig. 3 Immunophenotypic analysis of MSC by flow cytometry during monolayer expansion (prior to encapsulation in the hydrogel) and throughout
scaffold culture. a Hematopoietic markers and major histocompatibility complex class II molecule. b Mesenchymal surface markers. For mesenchymal
surface markers, the results are shown as percentages of positive cells. All results are expressed as mean ± standard error of the mean (n≥ 3). *p < 0.05,
**p < 0.01 and ***p < 0.001, day x vs day 0 (monolayer) for the same cell source. #p < 0.05, ##p < 0.01 and ###p < 0.001, WJ-MSC vs BM-MSC for the same
culture time. BM-MSC bone marrow-derived mesenchymal stromal/stem cells, WJ-MSC Wharton’s jelly-derived mesenchymal stromal/stem cells
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compared to BM-MSC. To explore the synthesis of vari-
ous collagens in depth, immunofluorescence and immu-
nohistochemistry staining were performed after 28 days
of chondrogenic induction (Fig. 5b, c). Regardless of
MSC source, collagen synthesis was pericellular and, as
shown in Fig. 5c, remained low compared to positive
control (human cartilage). Both cell types expressed type I
collagen. In contrast, WJ-MSC seemed to synthesize more
type II collagen, whereas BM-MSC seemed to produce
more type X collagen. These results obtained for matrix
synthesis analysis were consistent with those obtained for
transcript analysis.
Discussion
Today, thanks to their multiple properties and ease of
access, WJ-MSC seem to be an interesting source of
MSC for cartilage tissue engineering. The aim of this
work was to evaluate the chondrogenic potential of WJ-
MSC embedded in Alg/HA hydrogel, constructed by an
original spraying method, without adding growth factors
and to compare the results with those obtained with
standard BM-MSC. The culture model used in this study
has already been validated in previous studies [6, 20].
We showed that the spraying process contributes to
form a highly functional and structured biomaterial for
cartilage tissue engineering. In this present study, we in-
vestigated the potential for chondrogenic differentiation
of WJ-MSC maintained in scaffolds built by spraying
process. We then compared chondrogenic potential to
that obtained from BM-MSC. We focused on cell viabil-
ity, cell phenotype and evaluation of matrix synthesis
during chondrogenic differentiation.
Alginate hydrogel is considered a natural, polysaccharide-
based and biocompatible scaffold which creates a porous
microstructure and is therefore a viable environment for
cell culture [22]. Adult stem cells encapsulated in alginate
hydrogel exhibited viability greater than 95 % up to 28 days
of culture [23]. Very few studies have shown the impact
of seeding WJ-MSC in alginate hydrogel on cell viabil-
ity [24, 25]. Penolazzi et al. indicated that WJ-MSC, en-
capsulated in alginate microbeads, were highly viable
(about 90 %) after 6 days of culture [24]. In the present
Fig. 4 Relative expression of specific cartilage-related genes evaluated by quantitative RT-PCR during 28 days of chondrogenic induction. All re-
sults are expressed as mean ± standard error of the mean (n ≥ 3). *p < 0.05, **p < 0.01 and ***p < 0.001, day x vs day 3 for a same cell source. ###p
< 0.001, WJ-MSC vs BM-MSC for a same culture time. BM-MSC bone marrow-derived mesenchymal stromal/stem cells, COMP cartilage oligomeric
matrix protein, COL collagen, WJ-MSC Wharton’s jelly-derived mesenchymal stromal/stem cells
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Fig. 5 (See legend on next page.)
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study, we demonstrated an increase of sprayed WJ-
MSC viability (>80 %) at day 14 which was maintained
until the end of the culture. Few apoptotic and necrotic
cells found at day 3 seemed to be due to the spraying
method, and were eliminated in the last step of necro-
sis. This could explain the increase in sprayed cell via-
bility. However, in further work, it would be interesting
to evaluate cell number (DNA content) in hydrogel
during differentiation. These results are consistent with
those of a previous study which used BM-MSC under
the same conditions [6]. It was demonstrated that
spraying method effects are quite damaging to cell via-
bility and metabolic activity during the first 7 days of
culture [6]. To confirm our hypothesis and explain cell
mortality at day 3, we performed two methods of scaf-
fold construct: alginate beads and alginate cylinders
(obtained by spraying method) seeded with the same
WJ-MSC (Fig. 2c). The results indicated clearly that at
the third day of culture, viability of sprayed cells was
significantly lower than in cells embedded in alginate
beads. At the same time, cell apoptosis was significantly
higher in cylinders compared to cells seeded in beads.
Thus, we have shown that the spraying method can
transiently alter cell viability only during the onset of
culture. This could be explained by the fact that the im-
pact of cells on the support may induce the death of
some cells. After 3 days of culture, WJ-MSC seemed to
be adapted to their new 3D environment without any
detectable damage. Thus, these data are consistent with
previous reports [6, 20] and confirm that, even after the
spraying process, Alg/HA hydrogel remains an in vitro
biocompatible environment for 3D cell culture.
Cell characterization was performed by the study of
surface marker expression and analysis of Sox9 transcrip-
tion factor expression which are involved in chondrogenic
differentiation. During monolayer culture, WJ-MSC
expressed MSC surface markers (such as CD44, CD73,
CD90, CD105 and CD166) as reported in previous studies
[12, 26]. A very large number of WJ-MSC (almost 100 %)
were positive for CD73, CD90, CD105 and it was demon-
strated that expression of these markers by adult MSC
was clearly in favor of a chondrogenic potential [27–29].
In monolayer and in comparison with BM-MSC, the pro-
portion of CD44+, CD73+ and CD105+ WJ-MSC were sig-
nificantly higher. Upregulation of the HA receptor (CD44)
in WJ-MSC has been previously described and probably
results in the histological structure of the umbilical cord
matrix [30]. Indeed, according to histochemical analysis,
Wharton’s jelly contains significant amounts of HA [31].
Moreover, it is well known that scaffold composed of HA
may create an environment that can preserve the normal
phenotype of chondrocytes and may guide cell differenti-
ation to chondrogenesis [19]. A recent study showed that
human MSC interactions with HA hydrogels via CD44
and CD168 promote chondrogenesis and that specific
cell–material interactions play a role in this process. Be-
yond matrix interactions, cadherin molecules, a family of
transmembrane glycoproteins, play a critical role in tissue
development during embryogenesis, and N-cadherin is a
key factor in mediating cell–cell interactions during mes-
enchymal condensation and chondrogenesis [32]. In our
study, due to the presence of HA in alginate hydrogel, re-
gardless of the MSC source and during 3D culture, CD44
expression remained high and stable as mentioned in the
literature [18]. On the other hand, Lee et al. showed that
in alginate hydrogel, without hyaluronic acid, a marked
decrease of CD44 expression by BM-MSC was observed
after 2 weeks of culture [33]. CD73, an ecto-5’-nucleotid-
ase which plays a crucial role in extracellular adenosine
generation, is known to be a regulatory factor in chondro-
genic differentiation [34]. CD105 (endoglin), a membrane
glycoprotein which is part of the TGFβ receptor complex
[35], is considered a marker of stem cell chondrogenic po-
tential [36]. Moreover, it has been demonstrated that the
expression of these two markers decreases during chon-
drogenesis [33]. Thus, according to this phenotype profile
(particularly CD73 and CD105 expression), before seeding
in a 3D scaffold, WJ-MSC should have better chondro-
genic potential compared to BM-MSC. After cell embed-
ding in Alg/HA hydrogel and throughout culture, WJ-
MSC undergo significant phenotypic changes. From 14
and up to 28 days, the percentages of positive WJ-MSC
for mesenchymal markers (except CD44) decreased sig-
nificantly compared to monolayer marker expression.
These results are consistent with those of a previous study
showing similar data with BM-MSC seeded in alginate
hydrogel and cultivated with or without added growth
factor for 2 weeks [33]. In 3D culture, mesenchymal
marker expression levels decreased during the chondro-
genic differentiation process [33]. Nagase et al. showed
that CD90 was an important indicator of chondrogenic
differentiation potential of synovial MSC [37]. De-
creased CD90 expression was correlated with reduced
chondrogenic potential [37]. According to our results,
decreased expression of mesenchymal markers could
reflect a loss of undifferentiated character of WJ-MSC
(See figure on previous page.)
Fig. 5 Matrix synthesis detected after 28 days of chondrogenic induction. Proteoglycans and total collagen were stained by Alcian blue and Sirius
red (a), respectively. To explore the synthesis of various collagens in depth, immunofluorescence (b) and immunohistochemistry staining (c) were
performed and detected using fluorescence microscopy and light microscopy, respectively; scale bar = 100 μm. BM-MSC bone marrow-derived
mesenchymal stromal/stem cells, WJ-MSC Wharton’s jelly-derived mesenchymal stromal/stem cells
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and cell commitment to a differentiation pathway. In our
study, after 14 days of 3D culture, WJ-MSC and BM-MSC
showed different phenotype profiles. WJ-MSC positivity
for mesenchymal markers seemed to decrease compared
to BM-MSC, notably for CD90 and CD166 which were
significantly reduced. To confirm cell commitment to a
differentiation pathway, and particularly to chondrogene-
sis, we analyzed the expression of the critical chondro-
genic marker, Sox9 transcription factor. Chondrogenic
gene Sox9 was observed during in vitro induction of
chondrogenesis and promoted transcription of cartilage
protein such as type II collagen and aggrecan [2, 38]. Our
data showed that the relative expression of Sox9 was
highly increased between the 14th and 28th days of scaf-
fold culture and demonstrated WJ-MSC commitment to
chondrogenesis. A recent study using WJ-MSC seeded in
type I collagen hydrogel, but with a chondrogenic induc-
tion by growth factor (TGF-β1), described an early upreg-
ulation of Sox9 from the day 7 of culture [13]. Also, it is
known that the TGFβ receptor, via the Smad 2/3 pathway,
activated the Sox9 transcription factor [38].
Evaluation of matrix synthesis was evaluated at both
transcript and protein levels. Transcript expression was
only evaluated after 3 days of differentiation. In future
studies it would be interesting to perform day 0 transcript
expression to have a real control. Cartilage matrix is com-
posed of a network of specific molecules which give the
tissue its functional properties and notably its resistance
to mechanical stress [39]. After 28 days of scaffold cul-
ture, our results demonstrated a strong upregulation of
cartilage-specific transcript expression. This result is con-
sistent with those of previous studies using WJ-MSC em-
bedded in a 3D environment and stimulated by growth
factors [13, 15]. Type II collagen is the main collagen
found in physiological hyaline cartilage and provides its
tensile strength [39]. According to our results, after
4 weeks of chondrogenic differentiation WJ-MSC exhib-
ited greater type II collagen synthesis than BM-MSC, at
both transcript and protein levels. In a relevant study,
Wang et al. demonstrated that WJ-MSC seeded on poly-
glycolic acid scaffold, using growth factor, synthesized
nearly three times as much collagen production as BM-
MSC. However, the differentiation profile of WJ-MSC,
compared to BM-MSC, consisted of a larger amount of
type I collagen and a smaller amount of type II collagen
[40]. Based on our data, Alg/HA hydrogel scaffold seems
to be a suitable environment promoting type II collagen
synthesis by WJ-MSC. The fact that type IIa procollagen,
considered a chondroprogenitor cell marker, was still
present at 28 days seems to indicate incomplete or slow
chondrogenesis in WJ-MSC [41]. No significant difference
in proteoglycans synthesis was observed between WJ-
MSC and BM-MSC. Furthermore, our work highlights a
relevant result showing that WJ-MSC express type X
collagen at lower levels than BM-MSC, at both transcript
and protein levels and especially at 28 days. Type X colla-
gen is considered a relevant hypertrophic chondrocyte
marker [38] and serves as a framework for subsequent
matrix calcification [42]. Hypertrophic extracellular matrix
is functionally different to physiological hyaline cartilage
and tends to become similar to bone matrix. Hypertrophic
chondrocytes are associated with the final stage of MSC
chondrogenesis [2]. Moreover, our results showed that the
osteogenic transcription factor Runx2, also considered as
a hypertrophic chondrocyte marker, was not expressed by
WJ-MSC throughout culture compared to BM-MSC. A
major challenge for cartilage tissue engineering is to con-
trol hypertrophic differentiation and maintain a stable
chondrocyte phenotype [38]. In this context, according
to our results, after 28 days of chondrogenic differenti-
ation, WJ-MSC seem to be less committed towards
hypertrophy than BM-MSC. Finally, it is known that
MSC are able to differentiate into other mesodermic
lineages such as adipogenic differentiation. Therefore,
we reported that, regardless of MSC source, no expres-
sion of adipogenic transcription factor PPARγ was de-
tected during hydrogel culture.
Conclusions
Although numerous studies have shown the successful
chondrogenic induction of WJ-MSC in 3D scaffolds, our
work demonstrated chondrogenic differentiation of WJ-
MSC without adding growth factors. Once seeded in Alg/
HA hydrogel scaffold, WJ-MSC and BM-MSC have
different profiles of chondrogenic differentiation at both
transcript and protein levels. After 4 weeks, WJ-MSC, em-
bedded in a 3D environment, were able to adapt to their
environment and express specific cartilage-related genes
and matrix proteins. Due to their chondrogenic differenti-
ation potential, their low immunogenicity and the fact that
they are easy to obtain, today WJ-MSC represent a real al-
ternative source of stem cells for cartilage tissue engineer-
ing. In order to improve mimicking of the physiological
environment and enhance chondrogenic differentiation, it
would be interesting to apply mechanical stress [43], hyp-
oxic culture [44] and turn to stratified cartilage tissue
engineering. Our original spraying method could be used
to design new stratified engineered tissues through pro-
gressive cells and hydrogel layers spraying. In all events,
cartilage repair based on WJ-MSC embedded in Alg/HA
hydrogel remains to be examined further by preclinical
and clinical in vivo assays.
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